The efficacy of pre-operative erythropoietin therapy

dc.contributor.authorAniteye, E.A.
dc.contributor.authorSereboe, L.
dc.contributor.authorKotei, D.
dc.contributor.authorFrimpong-Boateng, K.
dc.contributor.authorAdu-Gyamfi, Y.
dc.date.accessioned2019-04-04T11:14:22Z
dc.date.available2019-04-04T11:14:22Z
dc.date.issued2007-07
dc.description.abstractObjective: To determine whether a single weekly low dose of erythropoietin (EPO), haematenics and antimalarials is effective in increasing the pre-operative haemoglobin of patients coming for potential blood losing surgery. Design: A prospective observational study. Setting: The Korle-bu Teaching Hospital, Accra, Ghana. Subjects: Thirty one patients with low haemoglobin scheduled for potential blood losing surgery. Results: A mean weekly dose of EPO administered of 10,840 ± 640 IU raised the haemoglobin by 2-5g% above baseline levels in 28 (90.3%) of the patients. Twenty five (81%) of the patients had an uneventful normovolaemic haemodilution during their surgery. Conclusion: A single weekly dose of 150 ug/kg of EPO, haematenics, chloroquine (anti-malarial) and a high protein diet is efficacious in raising the pre-operative haemoglobin in Ghanaian patients.en_US
dc.identifier.otherVol. 84(6): pp 279-82
dc.identifier.otherDOI: 10.4314/eamj.v84i6.9537
dc.identifier.urihttp://ugspace.ug.edu.gh/handle/123456789/29043
dc.language.isoenen_US
dc.publisherEast African Medical Journalen_US
dc.titleThe efficacy of pre-operative erythropoietin therapyen_US
dc.typeArticleen_US

Files

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.6 KB
Format:
Item-specific license agreed upon to submission
Description: